• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法尼醇乳剂作为一种有效的抗ESKAPE生物膜的广谱制剂。

Farnesol Emulsion as an Effective Broad-Spectrum Agent against ESKAPE Biofilms.

作者信息

Tan Li, Ma Rong, Katz Adam J, Levi Nicole

机构信息

Department of Plastic and Reconstructive Surgery, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

出版信息

Antibiotics (Basel). 2024 Aug 17;13(8):778. doi: 10.3390/antibiotics13080778.

DOI:10.3390/antibiotics13080778
PMID:39200078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11352207/
Abstract

The family of ESKAPE pathogens is comprised of , and . Together they are the main contributors of nosocomial infections and are well established for their ability to "escape" antibiotics. Farnesol is an FDA-approved cosmetic and flavoring agent with significant anti-biofilm properties. In a proprietary emulsion, farnesol has been shown to be capable of disrupting , and biofilms. The current work demonstrates that this farnesol emulsion reduces the number of viable bacteria, while also leading to reductions in biomass, of the other three ESKAPE pathogens: and both in vitro and in an ex vivo human skin model. A concentration of 0.5 mg/mL was effective for impeding biofilm development of all three bacteria, while 1 mg/mL for and , or 0.2 mg/mL for was able to kill bacteria in established biofilms. Contrary to antibiotics, no resistance to farnesol was observed for or . The results indicate that farnesol is effective for direct cell killing and also has the ability to induce biofilm detachment from surfaces, as confirmed using Live/Dead image analysis. Our findings confirm that farnesol emulsion is an effective broad-spectrum agent to impede ESKAPE biofilms.

摘要

ESKAPE 病原体家族由……组成。它们共同构成了医院感染的主要致病菌,并且以其 “逃避” 抗生素的能力而闻名。法尼醇是一种经美国食品药品监督管理局(FDA)批准的化妆品和调味剂,具有显著的抗生物膜特性。在一种专利乳液中,法尼醇已被证明能够破坏……生物膜。目前的研究表明,这种法尼醇乳液可减少其他三种 ESKAPE 病原体(……)的活菌数量,同时还能在体外和离体人类皮肤模型中减少生物量。0.5 mg/mL 的浓度可有效阻止这三种细菌的生物膜形成,而 1 mg/mL 对……或 0.2 mg/mL 对……能够杀死已形成生物膜中的细菌。与抗生素不同,未观察到……对法尼醇产生耐药性。结果表明,法尼醇对直接杀死细胞有效,并且如通过活/死图像分析所证实的那样,还具有诱导生物膜从表面脱离的能力。我们的研究结果证实,法尼醇乳液是一种有效的广谱制剂,可阻碍 ESKAPE 生物膜的形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/30941b6f7cf9/antibiotics-13-00778-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/e6425376c8f2/antibiotics-13-00778-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/a0dd8f206427/antibiotics-13-00778-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/7f912251bc8d/antibiotics-13-00778-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/957e6af2c400/antibiotics-13-00778-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/4971062a5c95/antibiotics-13-00778-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/5edb22b4cc2c/antibiotics-13-00778-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/be5baeddf209/antibiotics-13-00778-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/a6e02f4bad26/antibiotics-13-00778-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/c82758384897/antibiotics-13-00778-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/e364827c25f7/antibiotics-13-00778-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/30941b6f7cf9/antibiotics-13-00778-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/e6425376c8f2/antibiotics-13-00778-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/a0dd8f206427/antibiotics-13-00778-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/7f912251bc8d/antibiotics-13-00778-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/957e6af2c400/antibiotics-13-00778-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/4971062a5c95/antibiotics-13-00778-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/5edb22b4cc2c/antibiotics-13-00778-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/be5baeddf209/antibiotics-13-00778-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/a6e02f4bad26/antibiotics-13-00778-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/c82758384897/antibiotics-13-00778-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/e364827c25f7/antibiotics-13-00778-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/11352207/30941b6f7cf9/antibiotics-13-00778-g011.jpg

相似文献

1
Farnesol Emulsion as an Effective Broad-Spectrum Agent against ESKAPE Biofilms.法尼醇乳剂作为一种有效的抗ESKAPE生物膜的广谱制剂。
Antibiotics (Basel). 2024 Aug 17;13(8):778. doi: 10.3390/antibiotics13080778.
2
Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.人唾液蛋白组蛋白5对ESKAPE病原体具有强大的杀菌活性。
Front Cell Infect Microbiol. 2017 Feb 15;7:41. doi: 10.3389/fcimb.2017.00041. eCollection 2017.
3
Repurposing Farnesol for Combating Drug-Resistant and Persistent Single and Polymicrobial Biofilms.将法尼醇重新用于对抗耐药性和持续性单一及多微生物生物膜
Antibiotics (Basel). 2024 Apr 11;13(4):350. doi: 10.3390/antibiotics13040350.
4
Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.尼泊尔一家医院中ESKAPE病原体的特征分析,特别关注多重耐药性和生物膜形成
Infect Drug Resist. 2021 Jun 14;14:2201-2212. doi: 10.2147/IDR.S306688. eCollection 2021.
5
Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens.南极海洋细菌作为对抗ESKAPE病原体的抗生物膜分子来源
Antibiotics (Basel). 2023 Oct 21;12(10):1556. doi: 10.3390/antibiotics12101556.
6
Farnesol repurposing for prevention and treatment of biofilms.法尼醇用于生物膜预防和治疗的新用途。
Biofilm. 2024 Apr 20;7:100198. doi: 10.1016/j.bioflm.2024.100198. eCollection 2024 Jun.
7
Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.羧酸类诺氟沙星盐可抑制 ESKAPE 病原体的浮游和生物膜生长模式。
J Appl Microbiol. 2018 Feb;124(2):408-422. doi: 10.1111/jam.13651.
8
Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.不同 ESKAPE 病原体中的差异抗微生物次生代谢产物解释了它们在医院环境中的适应性。
Infect Genet Evol. 2018 Dec;66:57-65. doi: 10.1016/j.meegid.2018.09.010. Epub 2018 Sep 15.
9
Tolerance and Resistance of Biofilms to Antimicrobial Agents-How Can Escape Antibiotics.生物膜对抗菌剂的耐受性和抗性——如何逃避抗生素
Front Microbiol. 2019 May 3;10:913. doi: 10.3389/fmicb.2019.00913. eCollection 2019.
10
Antipathogenic Efficacy of Biogenic Silver Nanoparticles and Antibiofilm Activities Against Multi-drug-Resistant ESKAPE Pathogens.生物成因银纳米粒子的抗病原功效及针对多药耐药 ESKAPE 病原体的抗生物膜活性。
Appl Biochem Biotechnol. 2024 Apr;196(4):2031-2052. doi: 10.1007/s12010-023-04630-7. Epub 2023 Jul 18.

本文引用的文献

1
Farnesol repurposing for prevention and treatment of biofilms.法尼醇用于生物膜预防和治疗的新用途。
Biofilm. 2024 Apr 20;7:100198. doi: 10.1016/j.bioflm.2024.100198. eCollection 2024 Jun.
2
Repurposing Farnesol for Combating Drug-Resistant and Persistent Single and Polymicrobial Biofilms.将法尼醇重新用于对抗耐药性和持续性单一及多微生物生物膜
Antibiotics (Basel). 2024 Apr 11;13(4):350. doi: 10.3390/antibiotics13040350.
3
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic.耐抗生素的 ESKAPE 病原体与 COVID-19:大流行之外的大流行。
Viruses. 2023 Aug 30;15(9):1843. doi: 10.3390/v15091843.
4
Synergy with farnesol rejuvenates colistin activity against Colistin-resistant Gram-negative bacteria in vitro and in vivo.金合欢醇协同增强多粘菌素对耐多粘菌素革兰氏阴性菌的体外和体内活性。
Int J Antimicrob Agents. 2023 Sep;62(3):106899. doi: 10.1016/j.ijantimicag.2023.106899. Epub 2023 Jun 22.
5
ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic.“ESKAPE” 及其以外:新冠疫情中的合并感染负担
Pathogens. 2023 May 22;12(5):743. doi: 10.3390/pathogens12050743.
6
Coping with the ESKAPE pathogens: Evolving strategies, challenges and future prospects.应对 ESKAPE 病原体:不断发展的策略、挑战与未来前景。
Microb Pathog. 2023 Feb;175:105963. doi: 10.1016/j.micpath.2022.105963. Epub 2022 Dec 27.
7
PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease.巴黎法呢基化可预防帕金森病模型中的神经退行性变。
Sci Transl Med. 2021 Jul 28;13(604). doi: 10.1126/scitranslmed.aax8891.
8
Dual-Function Potentiation by PEG-BPEI Restores Activity of Carbapenems and Penicillins against Carbapenem-Resistant .聚乙二醇-聚乙烯亚胺的双功能增强作用恢复了碳青霉烯类和青霉素类对耐碳青霉烯类细菌的活性。
ACS Infect Dis. 2021 Jun 11;7(6):1657-1665. doi: 10.1021/acsinfecdis.0c00863. Epub 2021 May 4.
9
NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131.产NDM-1碳青霉烯酶肠杆菌科细菌对杀菌肽CSA-13、CSA-44和CSA-131高度敏感。
Infect Drug Resist. 2020 Sep 28;13:3277-3294. doi: 10.2147/IDR.S261579. eCollection 2020.
10
Bacterial Virulence Factors and Their Contribution to Pathophysiology after Thermal Injury.细菌毒力因子及其在热损伤后病理生理学中的作用。
Surg Infect (Larchmt). 2021 Feb;22(1):69-76. doi: 10.1089/sur.2020.188. Epub 2020 Jul 28.